These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 34923193)
1. Upregulated expression of DDX5 predicts recurrence and poor prognosis in breast cancer. Li K; Zhao G; Yuan H; Zhang J; Li Q; Gong D; Lin P Pathol Res Pract; 2022 Jan; 229():153736. PubMed ID: 34923193 [TBL] [Abstract][Full Text] [Related]
2. Upregulation of DEAD box helicase 5 and 17 are correlated with the progression and poor prognosis in gliomas. Luo Q; Que T; Luo H; Meng Y; Chen X; Huang H; Hu R; Luo K; Zheng C; Yan P; Gong J; Fu H; Liu J; Tang Q; Huang G Pathol Res Pract; 2020 Mar; 216(3):152828. PubMed ID: 32008867 [TBL] [Abstract][Full Text] [Related]
3. DDX5 promotes proliferation and tumorigenesis of non-small-cell lung cancer cells by activating β-catenin signaling pathway. Wang Z; Luo Z; Zhou L; Li X; Jiang T; Fu E Cancer Sci; 2015 Oct; 106(10):1303-12. PubMed ID: 26212035 [TBL] [Abstract][Full Text] [Related]
4. Loss of Dicer expression is associated with breast cancer progression and recurrence. Khoshnaw SM; Rakha EA; Abdel-Fatah TM; Nolan CC; Hodi Z; Macmillan DR; Ellis IO; Green AR Breast Cancer Res Treat; 2012 Sep; 135(2):403-13. PubMed ID: 22821364 [TBL] [Abstract][Full Text] [Related]
5. HAGE (DDX43) is a biomarker for poor prognosis and a predictor of chemotherapy response in breast cancer. Abdel-Fatah TM; McArdle SE; Johnson C; Moseley PM; Ball GR; Pockley AG; Ellis IO; Rees RC; Chan SY Br J Cancer; 2014 May; 110(10):2450-61. PubMed ID: 24755885 [TBL] [Abstract][Full Text] [Related]
6. Low expression of DDX5 is associated with poor prognosis in patients with pancreatic ductal adenocarcinoma. Morimachi M; Hirabayashi K; Takanashi Y; Kawanishi A; Saika T; Ueyama Y; Nakagohri T; Nakamura N; Suzuki H; Kagawa T J Clin Pathol; 2021 Nov; 74(11):741-745. PubMed ID: 33097588 [TBL] [Abstract][Full Text] [Related]
7. DDX5 promotes hepatocellular carcinoma tumorigenesis via Akt signaling pathway. Xue Y; Jia X; Li L; Dong X; Ling J; Yuan J; Li Q Biochem Biophys Res Commun; 2018 Sep; 503(4):2885-2891. PubMed ID: 30119889 [TBL] [Abstract][Full Text] [Related]
8. The BMP inhibitor DAND5 in serum predicts poor survival in breast cancer. Chi Y; Yao L; Hu X; Huang S; Huang N; Li S; Shao Z; Wu J Oncotarget; 2016 Mar; 7(12):14951-62. PubMed ID: 26908452 [TBL] [Abstract][Full Text] [Related]
9. Association of sonographic features and molecular subtypes in predicting breast cancer disease outcomes. Wang H; Yao J; Zhu Y; Zhan W; Chen X; Shen K Cancer Med; 2020 Sep; 9(17):6173-6185. PubMed ID: 32657039 [TBL] [Abstract][Full Text] [Related]
10. High levels of γ-glutamyl hydrolase (GGH) are associated with poor prognosis and unfavorable clinical outcomes in invasive breast cancer. Shubbar E; Helou K; Kovács A; Nemes S; Hajizadeh S; Enerbäck C; Einbeigi Z BMC Cancer; 2013 Feb; 13():47. PubMed ID: 23374458 [TBL] [Abstract][Full Text] [Related]
11. CYP27A1 expression is associated with risk of late lethal estrogen receptor-positive breast cancer in postmenopausal patients. Kimbung S; Inasu M; Stålhammar T; Nodin B; Elebro K; Tryggvadottir H; Ygland Rödström M; Jirström K; Isaksson K; Jernström H; Borgquist S Breast Cancer Res; 2020 Nov; 22(1):123. PubMed ID: 33176848 [TBL] [Abstract][Full Text] [Related]
12. NEDD4 expression is associated with breast cancer progression and is predictive of a poor prognosis. Wan L; Liu T; Hong Z; Pan Y; Sizemore ST; Zhang J; Ma Z Breast Cancer Res; 2019 Dec; 21(1):148. PubMed ID: 31856858 [TBL] [Abstract][Full Text] [Related]
13. RNA helicase DDX5 regulates microRNA expression and contributes to cytoskeletal reorganization in basal breast cancer cells. Wang D; Huang J; Hu Z Mol Cell Proteomics; 2012 Feb; 11(2):M111.011932. PubMed ID: 22086602 [TBL] [Abstract][Full Text] [Related]
14. Overexpression of long non-coding RNA CCAT1 is a novel biomarker of poor prognosis in patients with breast cancer. Zhang XF; Liu T; Li Y; Li S Int J Clin Exp Pathol; 2015; 8(8):9440-5. PubMed ID: 26464701 [TBL] [Abstract][Full Text] [Related]
15. Expression of microRNA-497 and its prognostic significance in human breast cancer. Wang S; Li H; Wang J; Wang D Diagn Pathol; 2013 Oct; 8():172. PubMed ID: 24143964 [TBL] [Abstract][Full Text] [Related]
16. High expression of ALDOA and DDX5 are associated with poor prognosis in human colorectal cancer. Dai L; Pan G; Liu X; Huang J; Jiang Z; Zhu X; Gan X; Xu Q; Tan N Cancer Manag Res; 2018; 10():1799-1806. PubMed ID: 29988738 [TBL] [Abstract][Full Text] [Related]
17. Breast cancer-specific survival in patients with lymph node-positive hormone receptor-positive invasive breast cancer and Oncotype DX Recurrence Score results in the SEER database. Roberts MC; Miller DP; Shak S; Petkov VI Breast Cancer Res Treat; 2017 Jun; 163(2):303-310. PubMed ID: 28243896 [TBL] [Abstract][Full Text] [Related]
18. HAGE, the helicase antigen as a biomarker for breast cancer prognosis (WO2013144616). Wiese M; Pajeva IK Expert Opin Ther Pat; 2014 Jun; 24(6):723-5. PubMed ID: 24766479 [TBL] [Abstract][Full Text] [Related]
19. The value of Nottingham grade in breast cancer re-visited in the Sri Lankan setting. Peiris H; Mudduwa L; Thalagala N; Jayatialake K Malays J Pathol; 2017 Aug; 39(2):141-148. PubMed ID: 28866695 [TBL] [Abstract][Full Text] [Related]
20. Endocrine sensitivity is decisive for patient outcome in small node-negative breast cancers (BC) (pT1a,b) - results from the Munich Cancer Registry. Kolben T; Harbeck N; Wuerstlein R; Schubert-Fritschle G; Bauerfeind I; Schrodi S; Engel J Breast; 2015 Feb; 24(1):24-31. PubMed ID: 25543874 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]